- Home
- RFIL vs INKT Comparison
RFIL vs INKT Comparison
Compare RFIL & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- INKT
- Stock Information
- Founded
- RFIL 1979
- INKT 2017
- Country
- RFIL United States
- INKT United States
- Employees
- RFIL N/A
- INKT N/A
- Industry
- RFIL Electrical Products
- INKT Medicinal Chemicals and Botanical Products
- Sector
- RFIL Technology
- INKT Health Care
- Exchange
- RFIL Nasdaq
- INKT Nasdaq
- Market Cap
- RFIL 44.7M
- INKT 28.8M
- IPO Year
- RFIL N/A
- INKT 2021
- Fundamental
- Price
- RFIL $6.86
- INKT $21.07
- Analyst Decision
- RFIL Strong Buy
- INKT Hold
- Analyst Count
- RFIL 1
- INKT 3
- Target Price
- RFIL $4.50
- INKT $37.50
- AVG Volume (30 Days)
- RFIL 176.7K
- INKT 2.9M
- Earning Date
- RFIL 09-15-2025
- INKT 08-12-2025
- Dividend Yield
- RFIL N/A
- INKT N/A
- EPS Growth
- RFIL N/A
- INKT N/A
- EPS
- RFIL N/A
- INKT N/A
- Revenue
- RFIL $73,399,000.00
- INKT N/A
- Revenue This Year
- RFIL $20.11
- INKT N/A
- Revenue Next Year
- RFIL $5.95
- INKT N/A
- P/E Ratio
- RFIL N/A
- INKT N/A
- Revenue Growth
- RFIL 20.14
- INKT N/A
- 52 Week Low
- RFIL $3.27
- INKT $4.56
- 52 Week High
- RFIL $7.61
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- RFIL 57.52
- INKT 55.06
- Support Level
- RFIL $5.55
- INKT $23.11
- Resistance Level
- RFIL $7.61
- INKT $76.00
- Average True Range (ATR)
- RFIL 0.48
- INKT 7.20
- MACD
- RFIL -0.08
- INKT 1.20
- Stochastic Oscillator
- RFIL 44.92
- INKT 23.55
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.